Product Information
IOPIDINE 1% EYE DROP is a brand product labeled by Harrow Eye, LLC, priced at $26.7049 per EA under NDC 82667020001. Its NADAC has been published 19 times since Feb 18, 2026.
Strength
10 mg/mL
Manufacturer
Harrow Eye, LLCNDC
82667020001
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
APRACLONIDINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA019779On Market Since
8/1/2023
Pharmacological Classes
Price Statistics
The NADAC for IOPIDINE 1% EYE DROP has been published 19 times since Feb 18, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.7049 per EA |
|---|---|
| All-time high | $26.7049 (Jun 24, 2026) |
| All-time low | $26.6268 (Feb 18, 2026) |
| 52-week high | $26.7049 |
| 52-week low | $26.6268 |
| Median price | $26.6268 |
| Average price | $26.6350 |
| Largest weekly change | +0.3% (Jun 17, 2026) |
| Weeks tracked | 19 |
| Tracking since | Feb 18, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the apraclonidine hydrochloride ophthalmic solution market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of IOPIDINE 1% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for IOPIDINE 1% EYE DROP, manufactured by Harrow Eye, LLC, is $26.7049 per EA (NDC 82667020001), effective Jun 24, 2026.
How has the price of IOPIDINE 1% EYE DROP changed over time?
Over the history we have for it, the NADAC for IOPIDINE 1% EYE DROP has held within roughly two percent of its current level. It has been tracked across 19 weekly CMS publications since Feb 18, 2026.
What are the highest and lowest recorded NADAC prices for IOPIDINE 1% EYE DROP?
Since Feb 18, 2026, the NADAC for IOPIDINE 1% EYE DROP has ranged from a low of $26.6268 (Feb 18, 2026) to a high of $26.7049 (Jun 24, 2026), with a median of $26.6268 per EA.
Are there cheaper alternatives to IOPIDINE 1% EYE DROP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of IOPIDINE 1% EYE DROP, so no direct lower-cost alternative is listed.
Who manufactures IOPIDINE 1% EYE DROP?
IOPIDINE 1% EYE DROP (NDC 82667020001) is labeled by Harrow Eye, LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification